ContextLogic Inc - Ordinary Shares - Class A
LOGC - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$706.89M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $706.89 Million |
|---|---|
| Enterprise Value | $905.79 Million |
| Earnings per Share | $-1.09 |
| Beta | 2.04 |
| Outstanding Shares | 45,737,000 |
Return
| Return on Equity | 2.81% |
|---|---|
| Return on Assets | 2.13% |
| Return on Invested Capital | -2.65% |
Valuation & Multiples
| P/E Ratio | -42.92 |
|---|---|
| PEG | -858.33 |
| Price to Sales | 15.4 |
| Price to Book Ratio | 0.96 |
| Enterprise Value to Revenue | 13.72 |
| Enterprise Value to EBIT | -36.07 |
| Enterprise Value to Net Income | 43 |
| Total Debt to Enterprise | 0.23 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.04
Consensus analyst estimateRevenue Estimate
$33.60 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.04
Consensus analyst estimateRevenue Estimate
$23.31 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.39%▲ 2.22% |
|---|---|
| Total Invested | $4.85M▲ 1828.26% |
| Investors Holding | 2▲ 1.00% |
About LogicBio Therapeutics Inc
39 employees
CEO: Frederic Chereau
LogicBio Therapeutics is a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood. The company's proprietary GeneRide™ platform is a...